Abstract
David Perrin studied biochemistry and economics at U.C. Berkeley. He then obtained a Ph.D. from U.C.L.A. under the supervision of Professor David Sigman where he worked on synthetic conjugates of phenanthroline to proteins and oligonucleotides. Following thesis work, he turned down a Fullbright fellowship in favor of an NSF fellowship to pursue postdoctoral research in the laboratory of Professor Claude Helene. This time was divided between a) the characterization of photoactive heterocycles that recognize triple-helical DNA structures and induce cleavage on the duplex B-DNA and b) combinatorial selections of synthetically modified DNA catalysts. He is currently an assistant professor of Chemistry at the University of British Columbia.
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Analytical Chemistry
Current Computer-Aided Drug Design
Current Bioactive Compounds
Current Cancer Drug Targets
Current Cancer Therapy Reviews
Current Diabetes Reviews
Current Drug Safety
Current Drug Targets
Related Books
2-Deoxy-D-Glucose: Chemistry and Biology
Chiral Ionic Liquids: Applications in Chemistry and Technology
Anthocyanins: Pharmacology and Nutraceutical Importance
Therapeutic Insights into Herbal Medicine through the Use of Phytomolecules
The Roles and Responsibilities of Clinical Pharmacists in Hospital Settings
Bioactive Compounds from Medicinal Plants for Cancer Therapy and Chemoprevention
Biochar - Solid Carbon for Sustainable Agriculture
DFT-Based Studies On Atomic Clusters
Basics of Organic Chemistry: A Textbook for Undergraduate Students
Science of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies
8